Medicare Part D coverage · 0.5 · RxCUI 730046
0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp]
Per the CMS 2026 Part D formulary file, 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] is covered by 1,364 Medicare Part D plans (27% of enrollable products), averaging Tier 4, with prior authorization required on 96.6% of covering formularies.
- 27%
- Plan coverage
- 1,364
- Plans covering
- T4
- Avg tier
- 96.6%
- Prior auth required
What the CMS Formulary Data Shows for 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp]
Per the CMS 2026 Part D formulary file, 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] (RxNorm concept RXCUI 730046, generic name 0.5) appears on 58 distinct formulary files spanning 1,364 Medicare Part D plan offerings - 27% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.
Real-world access to 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] depends on utilization management as much as tier placement: 96.6% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,574 Part D beneficiaries filled 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] in 2023, with total plan-and-beneficiary spending of $59,909,953 and an average per-beneficiary annual cost of $10,748.11. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] today.
Coverage Details
- Formularies covering
- 58
- Plans covering
- 1,364
- Coverage rate
- 27%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 96.6% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,574
- Total spending
- $59,909,953
- Avg per beneficiary
- $10,748.11
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | Yes | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | Yes | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | Yes | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | Yes | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | Yes | $5.00 | OK |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $13.10 | PA |
Show the next 30 plans
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $17.60 | PA |
| Highmark Health Options Duals Select (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $31.20 | DE |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $34.50 | NY |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T2 | Yes | $0 | CA |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Blue Medicare Essential Plus (HMO-POS) | Blue Cross AND Blue Shield OF North Carolina | T4 | Yes | $0 | NC |
| Blue Medicare Choice (HMO) | Blue Cross AND Blue Shield OF North Carolina | T4 | Yes | $0 | NC |
| Blue Medicare Essential (HMO) | Blue Cross AND Blue Shield OF North Carolina | T4 | Yes | $0 | NC |
| Experience Health Medicare Advantage (HMO) | Blue Cross AND Blue Shield OF North Carolina | T4 | Yes | $0 | NC |
| Healthy Blue + Medicare (HMO-POS D-SNP) | Blue Cross AND Blue Shield OF North Carolina | T4 | Yes | $0 | NC |
| Blue Advantage Complete (PPO) | Blue Cross AND Blue Shield OF Alabama | T4 | Yes | $0 | AL |
| Geisinger Gold Preferred Complete Rx (PPO) | Geisinger Indemnity Insurance Company | T4 | Yes | $0 | PA |
| Geisinger Gold Secure Rx (HMO D-SNP) | Geisinger Health Plan | T4 | Yes | $0 | PA |
| Geisinger Gold Classic 360 Rx (HMO) | Geisinger Health Plan | T4 | Yes | $0 | PA |
| Geisinger Gold Classic Essential Rx (HMO) | Geisinger Health Plan | T4 | Yes | $0 | PA |
| BSW SeniorCare Advantage (PPO) | Baylor Scott & White Insurance Company | T4 | Yes | $0 | TX |
| BSW SeniorCare Advantage Basic (PPO) | Baylor Scott & White Insurance Company | T4 | Yes | $0 | TX |
| BSW SeniorCare Advantage (PPO) | Baylor Scott & White Insurance Company | T4 | Yes | $0 | TX |
| BSW SeniorCare Advantage Select Rx (HMO-POS) | Scott AND White Health Plan | T4 | Yes | $0 | TX |
| BSW SeniorCare Advantage Premium Rx (HMO-POS) | Scott AND White Health Plan | T4 | Yes | $0 | TX |
| BSW SeniorCare Advantage Select Rx (HMO-POS) | Scott AND White Health Plan | T4 | Yes | $0 | TX |
| Blue Cross Medicare Advantage Classic (PPO) | Health Care Service Corporation | T4 | Yes | $0 | MT |
| Blue Cross Medicare Advantage Choice Plus (PPO) | Hcsc Insurance Services Company | T4 | Yes | $0 | TX |
| Blue Cross Medicare Advantage Choice Plus (PPO) | Hcsc Insurance Services Company | T4 | Yes | $0 | TX |
| Blue Cross Medicare Advantage Balance (PPO) | Hcsc Insurance Services Company | T4 | Yes | $0 | NM |
| Blue Cross Medicare Advantage Optimum (PPO) | Hcsc Insurance Services Company | T4 | Yes | $0 | NM |
| Blue Cross Medicare Advantage Access (PPO) | Hcsc Insurance Services Company | T4 | Yes | $0 | NM |
| Blue Cross Medicare Advantage Select (HMO) | Health Care Service Corporation | T4 | Yes | $0 | NM |
| Blue Cross Medicare Advantage Basic (HMO) | Health Care Service Corporation | T4 | Yes | $0 | IL |
| Blue Cross Medicare Advantage Basic (HMO) | Health Care Service Corporation | T4 | Yes | $0 | NM |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] covered by Medicare Part D?
Yes, 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] is covered by 1,364 Medicare Part D plans (27% of all Part D formularies).
What tier is 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] on Medicare Part D plans?
0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] averages Tier 4 across Part D plans, ranging from Tier 1 to Tier 5.
Does 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] require prior authorization?
96.6% of Part D formularies require prior authorization for 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp]?
In 2023, total Medicare Part D spending on 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] was $59,909,953, covering 5,574 beneficiaries. The average spend per beneficiary was $10,748.11.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray T4
- amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [Talicia] T4
- timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] T4
- deflazacort 18 MG Oral Tablet [Jaythari] T4
- bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] T4
- loteprednol etabonate 5 MG/ML Ophthalmic Suspension [Lotemax] T4
Similar prior-authorization rate
- 10 ML acyclovir 50 MG/ML Injection 96.6% PA
- tretinoin 0.5 MG/ML Topical Lotion [Altreno] 96.6% PA
- 1 ML darbepoetin alfa 0.06 MG/ML Injection [Aranesp] 96.6% PA
- 0.3 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe [Aranesp] 96.6% PA
- 0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe [Aranesp] 96.6% PA
- 0.6 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe [Aranesp] 96.6% PA